Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyoderma gangrenosum.

J G Hickman

    Clinics in Dermatology
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Pyoderma gangrenosum is a dramatic skin condition diagnosed clinically. While its cause remains unclear, new treatments offer personalized options for this poorly understood disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.

    Journal of cutaneous medicine and surgery·2001
    Same author

    Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair.

    Current medical research and opinion·2001
    Same author

    Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.

    Cutis·1999
    Same author

    A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor.

    Journal of the American Academy of Dermatology·1996
    Same author

    Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.

    Journal of the American Academy of Dermatology·1992
    Same author

    A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.

    Journal of the American Academy of Dermatology·1991
    Same journal

    Letter to the editor in reply to "Ethics of Rising Trends in Dermatology Publications Using Large-Scale Databases".

    Clinics in dermatology·2026
    Same journal

    Ethics of suggesting image-guided superficial radiation therapy on the pathology report.

    Clinics in dermatology·2026
    Same journal

    Tanorexia: The psychodermatology of compulsive tanning.

    Clinics in dermatology·2026
    Same journal

    Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.

    Clinics in dermatology·2026
    Same journal

    Discovery of an intravenous drug injection site: A meticulous cutaneous examination provides the forensic dermatologic clue to a diagnosis of homicide.

    Clinics in dermatology·2026
    Same journal

    Sherlock Holmes and the mystery of the deadly diet.

    Clinics in dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Immunology
    • Internal Medicine

    Background:

    • Pyoderma gangrenosum (PG) is a rare, inflammatory skin disease with a dramatic presentation.
    • First described 50 years ago, PG remains challenging to diagnose and understand.
    • It can occur independently or alongside various systemic disorders.

    Purpose of the Study:

    • To review the current understanding of pyoderma gangrenosum.
    • To highlight diagnostic challenges and evolving insights into its pathogenesis.
    • To discuss contemporary treatment strategies and their individualization.

    Main Methods:

    • Review of clinical observations and diagnostic criteria for PG.
    • Analysis of recent research on immunologic abnormalities associated with PG.

    Related Experiment Videos

  • Synthesis of current therapeutic approaches and their efficacy.

    • Main Results:

    • Clinical observation remains the cornerstone of PG diagnosis.
    • Numerous immunologic abnormalities are increasingly identified, yet pathogenesis is elusive.
    • PG is recognized as both a distinct entity and a co-condition in systemic diseases.

    Conclusions:

    • Pyoderma gangrenosum is a clinically recognizable but poorly understood dermatosis.
    • Despite advances, understanding its underlying pathogenesis requires further investigation.
    • Individualized treatment approaches are crucial given the availability of new therapeutic options.